Audit Trail Review in Pharma: Step-by-Step Method to Detect Data Integrity Issues Before Inspection

Описание: In this video, we break down Audit Trail Review (How to Do It) in a practical way for pharmaceutical, biotech, and GMP-regulated teams. Built around the topic "Audit Trail Review in Pharma: Step-by-Step Method to Detect Data Integrity Issues Before Inspection," this session explains where companies get exposed during audits, inspections, and internal quality reviews. The core risk is straightforward: If audit trails aren’t reviewed, you can’t detect changes that impact GMP decisions. Final reports show final state. Audit trails show the full history. Inspectors know exactly where to look: reprocessing, deletes, overrides, late edits. We walk through the actions that matter most in the real world—define what “audit trail review” means per system Not generic. Chromatography ≠ LIMS ≠ MES. set review frequency tied to risk Release-critical data: review before batch disposition. Stability: review per pull point and trending cycles. define escalation triggers Admin activity, multiple reprocess events, late edits after approval, deletes, clock changes. You will also see what should be documented, including audit trail review sop, checklists, evidence of review, exceptions handling, roles and responsibilities., the common mistake that creates repeat findings—calling “report review” an “audit trail review.”—and what inspectors typically focus on: they request audit trail records for a released batch and compare them with your narrative.. This video is useful for QA, QC, manufacturing, validation, engineering, IT, regulatory, and quality systems professionals who need clear, inspection-ready guidance instead of generic theory. It is ideal for training, SOP improvement, audit readiness, gap assessment, CAPA planning, and strengthening day-to-day GMP compliance and data integrity culture. Visit our website for more pharma compliance and regulatory content: https://www.pharmaregulatory.in and https://www.pharmagmp.in